Anavex Life Sciences Corp (AVXL)

[seventhwave]

Biostockclub, nice critical analysis and here's another take:
I wouldn't expect a serious partner or investor pulling the trigger without seeing PK/PD data. With 32(25) patients in this study, the PK/PD needs to be that much more conclusive. Missling said something to the effect we have the tip of the iceberg so far and PK/PD is the real McCoy. So yeah, everyone on this board should be craving for it and partners/inlicencers/investors are unlikely to make decisions before seeing it. Knoll is a one-trick-pony who is known to place his bets very early and Park West is a newbie in the biotech space with no other compelling names among their holdings. On a sidenote, Ariana will be producing alternate statistical measures (or so I gathered from info on their website) which I hope have a history of acceptance by the FDA.
FYI the stock market certainly doesn't think much about Neurotrope. Someone pointed out SLB rate at 120% already, a full month before data release. It means prople are desperate to position themselves from the expected downside. Their story/protocol around their candidate wasn't inspiring to me and I'm not doubting the market.